Pfizer expects $26 billion in 2021 sales from COVID vaccine

Pfizer said Tuesday it expects to do $26 billion in sales this year from its two-shot COVID-19 vaccine alone.

That’s up more than 70 percent from its last forecast, largely thanks to new contracts signed with countries struggling to get their hands on vaccine doses.

The estimate assumes that Pfizer will deliver 1.6 billion doses of its COVID-19 vaccine in 2021. Across all of its products, Pfizer said in its first-quarter earnings report that it expects to make between $70.5 billion and $72.5 billion in revenue this year.